Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America
Guest editors: K.S. Jagannatha Rao, Gabrielle B. Britton, Luisa Lilia Rocha Arrieta, Norberto Garcia-Cairasco, Alberto Lazarowski, Adrián Palacios, Antoni Camins Espuny and Ricardo B. Maccioni
Article type: Review Article
Authors: Guzman-Martinez, Leonardoa | Calfío, Camilaa | Farias, Gonzalo A.c | Vilches, Cristiand | Prieto, Raule | Maccioni, Ricardo B.a; b; *
Affiliations: [a] Laboratory of Neuroscience and Functional Medicine, International Center for Biomedicine and Faculty of Sciences, University of Chile, Santiago, Chile | [b] Department of Neurology, Faculty of Medicine East, University of Chile, Santiago, Chile | [c] Department of Neurology, Faculty of Medicine North, University of Chile, Santiago, Chile | [d] Center of Chinese Medicine, Santiago, Chile | [e] Traumatological Institute of Chile, Santiago, Chile
Correspondence: [*] Correspondence to: Ricardo B. Maccioni, MD, PhD, International Center for Biomedicine, Avda. Vitacura 3568, D511-512, Vitacura, Santiago, Chile. E-mail: rmaccioni45@gmail.com.
Abstract: One of the major puzzles in medical research and public health systems worldwide is Alzheimer’s disease (AD), reaching nowadays a prevalence near 50 million people. This is a multifactorial brain disorder characterized by progressive cognitive impairment, apathy, and mood and neuropsychiatric disorders. The main risk of AD is aging; a normal biological process associated with a continuum dynamic involving a gradual loss of people’s physical capacities, but with a sound experienced view of life. Studies suggest that AD is a break from normal aging with changes in the powerful functional capacities of neurons as well as in the mechanisms of neuronal protection. In this context, an important path has been opened toward AD prevention considering that there are elements of nutrition, daily exercise, avoidance of toxic substances and drugs, an active social life, meditation, and control of stress, to achieve healthy aging. Here, we analyze the involvement of such factors and how to control environmental risk factors for a better quality of life. Prevention as well as innovative screening programs for early detection of the disease using reliable biomarkers are becoming critical to control the disease. In addition, the failure of traditional pharmacological treatments and search for new drugs has stimulated the emergence of nutraceutical compounds in the context of a “multitarget” therapy, as well as mindfulness approaches shown to be effective in the aging, and applied to the control of AD. An integrated approach involving all these preventive factors combined with novel pharmacological approaches should pave the way for the future control of the disease.
Keywords: Alzheimer’s disease, biomarkers, early detection, meditation, non-pharmacological treatment, nutraceutical compounds, prevention, Traditional Chinese Medicine, Qigong and Taijiquan
DOI: 10.3233/JAD-201059
Journal: Journal of Alzheimer's Disease, vol. 82, no. s1, pp. S51-S63, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl